2470
Our findings suggest that hyperkalemia can develop with the use of low-dose heparin, within seven days of initiating heparin therapy, and that patients with diabetes mellitus or chronic renal insufficiency are especially predisposed to this complication.
 patients with diabetes mellitus or chronic renal insufficiency: Subject; diabetes mellitus: Subject.Disorder; chronic renal insufficiency: Subject.Disorder; hyperkalemia: Effect; low-dose heparin, within seven days of initiating heparin therapy: Treatment; low-dose: Treatment.Dosage; heparin: Treatment.Drug; within seven days: Treatment.Time_elapsed
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients with diabetes mellitus or chronic renal insufficiency: Subject; diabetes mellitus: Subject.Disorder; chronic renal insufficiency: Subject.Disorder; hyperkalemia: Effect; low-dose heparin, within seven days of initiating heparin therapy: Treatment; low-dose: Treatment.Dosage; heparin: Treatment.Drug; within seven days: Treatment.Time_elapsed